5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation (original) (raw)

References

• Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP . 1998. Adv Cancer Res 72: 141–196.
• Baylin SB, Hoppener JW, de Bustros A, Steenbergh PH, Lips CJ, Nelkin BD . (1986). Cancer Res 46: 2917–2922.
• Bender CM, Pao MM, Jones PA . (1998). Cancer Res 58: 95–101.
• Bovenzi V, Momparler RL . (2001). Cancer Chemother Pharmacol 48: 71–76.
• Boyes J, Bird A . (1991). Cell 64: 1123–1134.
• Christman JK . (2002). Oncogene 21: 5483–5495.
• Coombes MM, Briggs KL, Bone JR, Clayman GL, El-Naggar AK, Dent SY . (2003). Oncogene 22: 8902–8911.
• Creusot F, Acs G, Christman JK . (1982). J Biol Chem 257: 2041–2048.
• Daskalakis M, Nguyen TT, Nguyen C, Guldberg P, Kohler G, Wijermans P et al. (2002). Blood 100: 2957–2964.
• Domann FE, Rice JC, Hendrix MJ, Futscher BW . (2000). Int J Cancer 85: 805–810.
• Fahrner JA, Eguchi S, Herman JG, Baylin SB . (2002). Cancer Res 62: 7213–7218.
• Fuks F, Hurd PJ, Deplus R, Kouzarides T . (2003a). Nucleic Acids Res 31: 2305–2312.
• Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T . (2003b). J Biol Chem 278: 4035–4040.
• Futscher BW, O’Meara MM, Kim CJ, Rennels MA, Lu D, Gruman LM et al. (2004). Neoplasia 6: 380–389.
• Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H et al. (2002). Nat Genet 31: 175–179.
• Gardiner-Garden M, Frommer M . (1987). J Mol Biol 196: 261–282.
• Geiman TM, Sankpal UT, Robertson AK, Zhao Y, Robertson KD . (2004). Biochem Biophys Res Commun 318: 544–555.
• Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM et al. (1995). Cancer Res 55: 4531–4535.
• Heard E, Rougeulle C, Arnaud D, Avner P, Allis CD, Spector DL . (2001). Cell 107: 727–738.
• Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP et al. (1998). Proc Natl Acad Sci USA 95: 6870–6875.
• Hsi LC, Xi X, Wu Y, Lippman SM . (2005). Mol Cancer Ther 4: 1740–1746.
• Huang C, Sloan EA, Boerkoel CF . (2003). Curr Opin Genet Dev 13: 246–252.
• Issa JP, Garcia-Manero G, Giles FJ, Mannari R, Thomas D, Faderl S et al. (2004). Blood 103: 1635–1640.
• Jaenisch R, Bird A . (2003). Nat Genet 33 (Suppl): 245–254.
• Jones PA, Takai D . (2001). Science 293: 1068–1070.
• Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N . (1998). Nat Genet 19: 187–191.
• Juttermann R, Li E, Jaenisch R . (1994). Proc Natl Acad Sci USA 91: 11797–11801.
• Kantarjian HM, Issa JP . (2005). Semin Hematol 42: S17–S22.
• Kantarjian HM, O’Brien S, Cortes J, Giles FJ, Faderl S, Issa JP et al. (2003). Cancer 98: 522–528.
• Karpf AR, Jones DA . (2002). Oncogene 21: 5496–5503.
• Koch PJ, Franke WW . (1994). Curr Opin Cell Biol 6: 682–687.
• Kondo Y, Shen L, Issa JP . (2003). Mol Cell Biol 23: 206–215.
• Kondo Y, Shen L, Yan PS, Huang TH, Issa JP . (2004). Proc Natl Acad Sci USA 101: 7398–7403.
• Koul S, Houldsworth J, Mansukhani MM, Donadio A, McKiernan JM, Reuter VE et al. (2002). Mol Cancer 1: 8.
• Litt MD, Simpson M, Recillas-Targa F, Prioleau MN, Felsenfeld G . (2001). EMBO J 20: 2224–2235.
• Lubbert M, Wijermans P, Kunzmann R, Verhoef G, Bosly A, Ravoet C et al. (2001). Br J Haematol 114: 349–357.
• Miao F, Natarajan R . (2005). Mol Cell Biol 25: 4650–4661.
• Michalowsky LA, Jones PA . (1987). Mol Cell Biol 7: 3076–3083.
• Momparler RL, Bouchard J, Samson J . (1985). Leuk Res 9: 1361–1366.
• Mund C, Hackanson B, Stresemann C, Lubbert M, Lyko F . (2005). Cancer Res 65: 7086–7090.
• Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G et al. (2002). Cancer Res 62: 6456–6461.
• Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O’Carroll D et al. (2001). Nature 412: 561–565.
• Oshiro M, Kim C, Wozniak R, Junk D, Munoz-Rodriguez J, Burr J et al. (2005). Breast Cancer Res 7: R669–R680.
• Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE et al. (2003). Oncogene 22: 3624–3634.
• Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ . (1995). Oncogene 11: 1211–1216.
• Oue N, Shigeishi H, Kuniyasu H, Yokozaki H, Kuraoka K, Ito R et al. (2001). Int J Cancer 93: 805–809.
• Peters AH, Kubicek S, Mechtler K, O’Sullivan RJ, Derijck AA, Perez-Burgos L et al. (2003). Mol Cell 12: 1577–1589.
• Pliml J, Sorm F . (1964). Collect Czechoslovak Chem Commun 29: 2576–2577.
• Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF et al. (2003). Mol Cell 12: 1591–1598.
• Rice JC, Futscher BW . (2000). Nucleic Acids Res 28: 3233–3239.
• Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW . (2000). Carcinogenesis 21: 1761–1765.
• Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP . (2000). Nat Genet 25: 338–342.
• Rosenfeld CS . (2005). Semin Oncol 32: 465–472.
• Samlowski WE, Leachman SA, Wade M, Cassidy P, Porter-Gill P, Busby L et al. (2005). J Clin Oncol 23: 3897–3905.
• Santini V, Kantarjian HM, Issa JP . (2001). Ann Intern Med 134: 573–586.
• Scott SA, Dong WF, Ichinohasama R, Hirsch C, Sheridan D, Sanche SE et al. (2006). Leuk Res 30: 69–76.
• Smale ST . (1997). Biochim Biophys Acta 1351: 73–88.
• Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X et al. (2001). Nature 409: 207–211.
• Suzuki Y, Taira H, Tsunoda T, Mizushima-Sugano J, Sese J, Hata H et al. (2001). EMBO Rep 2: 388–393.
• Takai D, Jones PA . (2002). Proc Natl Acad Sci USA 99: 3740–3745.
• Tamame M, Antequera F, Santos E . (1988). Mol Cell Biol 8: 3043–3050.
• Tamame M, Antequera F, Villanueva JR, Santos T . (1983). Mol Cell Biol 3: 2287–2297.
• Trent J, Yang JM, Emerson J, Dalton W, McGee D, Massey K et al. (1993). Genes Chromosomes Cancer 7: 194–203.
• Wijermans P, Lubbert M, Verhoef G, Bosly A, Ravoet C, Andre M et al. (2000). J Clin Oncol 18: 956–962.
• Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W et al. (2001). Oncogene 20: 7787–7796.

Download references